Company / Operating Income
Zimmer Biomet Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$1.1B
FY2025
5-year range
$696.3M / $1.3B
FY2021-FY2025
Trend
-14.6%
vs FY2024
Sector context
#29 of 156
Health Care
What the data says
Zimmer Biomet's operating income of $1.1B is higher than 81% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from $83M in FY2020 to $1.3B in FY2024.
Based on SEC 10-K filings.
$1.1B in FY2025 with a 5-year CAGR of +67.6%. Top quartile in the Health Care sector.
Declined from $1.3B to $1.1B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +16.4%
- 5-Year CAGR
- +67.6%
- 10-Year CAGR
- -
Sector benchmark
+49.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +67.6%, indicating consistent growth.
- In FY2025, operating income decreased 14.6% year-over-year.
- Ranks #29 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1B | -14.6% |
| FY2024 | $1.3B | +0.6% |
| FY2023 | $1.3B | +83.5% |
| FY2022 | $696.3M | -19.1% |
| FY2021 | $860.3M | +935.3% |
| FY2020 | $83.1M | -89.6% |
| FY2019 | $799.3M | -2.7% |
| FY2018 | $821.1M | +2.7% |
| FY2017 | $799.3M | -22.9% |
| FY2016 | $1.0B | +122.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026